New Zealand - English - Medsafe (Medicines Safety Authority)

leo pharma limited - betamethasone dipropionate 0.5 mg/g;  ; calcipotriol 50 µg/g (as hydrate) - topical gel - 50 mcg - active: betamethasone dipropionate 0.5 mg/g   calcipotriol 50 µg/g (as hydrate) excipient: butylated hydroxytoluene hydrogenated castor oil liquid paraffin nitrogen polyoxypropylene monostearyl ether tocoferols - topical treatment of scalp psoriasis

Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - betamethasone; calcipotriol - gel - 50 microgram/g +0.5 milligram(s)/gram - calcipotriol, combinations

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - calcipotriol monohydrate, betamethasone dipropionate - ointment - calcipotriol monohydrate 50 microgram(s)/gram ; betamethasone dipropionate 0.5 milligram(s) - antipsoriatics

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dksh malaysia sdn. bhd. - betamethasone dipropionate; calcipotriol monohydrate -

Canada - English - Health Canada

teva canada limited - betamethasone (betamethasone dipropionate); calcipotriol - ointment - 0.5mg; 50mcg - betamethasone (betamethasone dipropionate) 0.5mg; calcipotriol 50mcg - anti-inflammatory agents

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dermapharm ag - calcipotriol monohydrate 0,052 mg/g - eq. calcipotriol 0,05 mg/g; betamethasone dipropionate 0,643 mg/g - eq. betamethasone 0,5 mg/g - ointment - 50 µg/g - 0,5 mg/g - calcipotriol monohydrate 0.052 mg/g; betamethasone dipropionate 0.643 mg/g - calcipotriol, combinations

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g; calcipotriol 0.05 mg/g;   - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone base 0.500 mg/g calcipotriol 0.05 mg/g   excipient: butylated hydroxytoluene liquid paraffin polyoxypropylene monostearyl ether white soft paraffin - calcipotriol /betamethasone (teva) is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in adult patients 18 years and older.

Malta - English - Medicines Authority

leo pharma a/s industriparken 55, 2750-dk ballerup, denmark - calcipotriol monohydrate, betamethasone dipropionate - cutaneous foam - calcipotriol monohydrate 50 µg/g betamethasone dipropionate 0.5 mg/g - antipsoriatics

New Zealand - English - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg; calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg - topical ointment - active: betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg excipient: d-alpha tocoferol liquid paraffin oleyl alcohol white soft paraffin - calcipotriol and betamethasone ointment is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in patients 18 years and older.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

leo pharma - betamethasone dipropionate; calcipotriol monohydrate - cutaneous gel - 500microgram/1gram ; 50microgram/1gram